Conor Medsystems
J&J’s Conor MedSystems can’t slip $100M Biotronik lawsuit
Johnson & Johnson (NYSE:JNJ) subsidiary Conor MedSystems can’t slip a $100 million breach of contract lawsuit filed by former European distribution partner Biotronik, a New York state appeals court ruled last week.
St. Jude CEO’s jibes at Medtronic, Med-tech weapon woes, Vaginal mesh and FDA reviews, Abbott’s split, Sunshine laws, Biotronik “sham recall” allegations and good news for heart valves made headlines this week | MassDevice.com +7
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
Biotronik weathers a blow in “sham recall” case against Johnson & Johnson
A New York State Supreme Court judge dealt a blow to Biotronik AG’s case against Johnson & Johnson (NYSE:JNJ) subsidiary Conor Medsystems over their defunct deal to distribute a drug-eluting stent.
Biotronik: J&J ran “sham” recall | Legal Roundup
A Johnson & Johnson (NYSE:JNJ) subsidiary allegedly issued a sham recall of its drug-eluting CoStar coronary stent and spiked a distribution deal with Biotronik AG that cost the German medical device giant $100 million, according to a lawsuit filed in New York’s highest court.
Biotronik accuses J&J subsidiary of “sham” recall
A Johnson & Johnson (NYSE:JNJ) subsidiary allegedly issued a sham recall of its drug-eluting CoStar coronary stent and spiked a distribution deal with Biotronik AG that cost the German medical device giant $100 million, according to a lawsuit filed in New York’s highest court.